All AbMole products are for research use only, cannot be used for human consumption.
Tripterin (Celastrol) is a proteasome inhibitor which potently and preferentially inhibits the chymotrypsin-like activity of a purified 20S proteasome with IC50 of 2.5 μM. Celastrol down-regulated the basal and DNA damaging agents-induced monoubiquitination of FANCD2, followed by proteolytic degradation. Celastrol treatment abrogated the G2 checkpoint induced by IR,and enhanced the ICL agents-induced DNA damage and inhibitory effects on lung cancer cells through depletion of FANCD2.Celastrol presented striking growth inhibition and apoptosis induction potency on DU145 cells in vitro in a time- and dose-dependent manner.Celastrol exhibits its antiprostate cancer effects partially through the downregulation of the expression level of hERG channel in DU145 cells,suggesting that celastrol may be a potential agent against prostate cancer with a mechanism of blocking the hERG channel.Celastrol ameliorates experimental colitis in IL-10 deficient mice via the up-regulation of autophagy by suppressing the PI3K/Akt/mTOR signaling pathway.Celastrol has the potential to inhibit cytochrome P450 activities and may cause the herb-drug interactions.Celastrol induces apoptosis in TNBC cells and indicated that apoptosis might be mediated through mitochondrial dysfunction and PI3K/Akt signaling pathway.
ACS Appl Mater Interfaces. 2024 Sep 11;16(36):47270-47283.
Engineered Carrier-Free Nanosystem-Induced In Situ Therapeutic Vaccines for Potent Cancer Immunotherapy
Celastrol purchased from AbMole
Front Microbiol. 2023 Mar 2;14:1120048.
Specific TLR-mediated HSP70 activation plays a potential role in host defense against the intestinal parasite Giardia duodenalis
Celastrol purchased from AbMole
Cell Experiment | |
---|---|
Cell lines | RPMI 8226, KATOIII, UM-SCC1, U251MG and MDA-MB-231 cells |
Preparation method | Determining the anti-proliferative effect of celastrol on various human tumor cell lines by the MTT uptake method. Briefly, incubating 5×103 cells with Celastrol in triplicate in a 96-well plate at 37 ℃. Then adding MTT solution to each well. After a 2 hours incubation at 37 ℃, adding extraction buffer (20% SDS, 50% dimethylformamide) , incubating cells overnight at 37 ℃, and then measuring the optical density at 570 nm using a Tecan plate reader. |
Concentrations | ~5 μM |
Incubation time | 2 hours |
Animal Experiment | |
---|---|
Animal models | nude mice bearing C4-2B tumors |
Formulation | 10% DMSO, 70% Cremophor/ethanol (3:1), and 20% PBS |
Dosages | 3 mg/kg |
Administration | Intraperitoneal injection |
Molecular Weight | 450.61 |
Formula | C29H38O4 |
CAS Number | 34157-83-0 |
Solubility (25°C) | DMSO ≥ 30 mg/mL |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
Related Proteasome Products |
---|
Proteasome inhibitor IX
Proteasome inhibitor IX (PS-IX; AM114) is a Chalcone derivative and a chymotrypsin-like activity of the 20S proteasome inhibitor with an IC50 value of ~1 μM. |
NIC-0102
NIC-0102 is an orally potent proteasome inhibitor (pIC50=7.55) that specifically inhibits NLRP3 inflammasome activation.NIC-0102 showed potent anti-inflammatory effects in vivo in a DSS-induced ulcerative colitis model. In addition, NIC-0102 inhibited the production of pro-IL-1β. |
Ac-WLA-AMC
Ac-WLA-AMC is a specific 20S constitutive proteasome β5 fluorogenic substrate. |
Ac-Nle-Pro-Nle-Asp-AMC
Ac-Nle-Pro-Nle-Asp-AMC is a specific substrate for 26S proteasome. |
PR-39
PR-39, a natural proline- and arginine-rich antibacterial peptide, is a noncompetitive, reversible and allosteric proteasome inhibitor. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.